BioWorld MedTech

April 4, 2011

ACOs set to change device maker, customer relationship

ATLANTA – With the impending formation of Accountable Care Organizations (ACOs), med-tech companies will have to alter the way they market their products to customers – because the customers will change. (Medical Device Daily) Read More

Radioembolization, the newest liver cancer-busting treatment

Washington roundup: Matrixx decision could prompt more data dumps in SEC filings

Palomar releases Icon Laser and Optimized Light System

International report: Best Medical Belgium acquires MDS Nordion

Court Report: Medtronic wins suit over Boston Sci heart patents

MDD's Fun Facts

Deals roundup: 3M reports the acquisition of assets from Zargis Medical

HIT roundup: SXC to provide PBM services for Nevada Medicaid program

Financings roundup: Thoratec to redeem all outstanding senior notes

Agreements/contracts: AutoGenomics expands molecular testing with PGXL

Product Briefs

People in the News

MDD's Neurology Extra

Today's news in brief

BioWorld

BioWorld briefs for May 22, 2026.

Acid alpha-glucosidase molecular structure isolated on black

‘Detargeted’ targeted gene therapy improves activity in Pompe

BioWorld

A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...

News in brief

BioWorld Asia

BioWorld Asia briefs for May 19, 2026

Genescience presents STAT6 degrader for atopic dermatitis

BioWorld Science

Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....

Roche reports new TREM2 agonists

BioWorld Science

F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...